Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Chemours (CC) EPS (Weighted Average and Diluted) (2016 - 2025)

Chemours (CC) has 12 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.03 in Q1 2025.

  • For Q1 2025, EPS (Weighted Average and Diluted) fell 108.33% year-over-year to -$0.03; the TTM value through Mar 2025 reached $0.17, up 107.73%, while the annual FY2024 figure was $0.47, 491.67% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.03 in Q1 2025 per CC's latest filing, up from -$0.08 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.52 in Q3 2022 and bottomed at -$2.52 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.36, with a median of $0.39 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 1163.64% in 2021, then tumbled 325.0% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.39 in 2021, then tumbled by 140.29% to -$0.56 in 2022, then skyrocketed by 78.57% to -$0.12 in 2023, then surged by 33.33% to -$0.08 in 2024, then surged by 62.5% to -$0.03 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.03 in Q1 2025, -$0.08 in Q4 2024, and -$0.18 in Q3 2024.